- Home
- DOCS vs ASND Comparison
DOCS vs ASND Comparison
Compare DOCS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCS
- ASND
- Stock Information
- Founded
- DOCS 2010
- ASND 2006
- Country
- DOCS United States
- ASND Denmark
- Employees
- DOCS N/A
- ASND N/A
- Industry
- DOCS Retail: Computer Software & Peripheral Equipment
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- DOCS Technology
- ASND Health Care
- Exchange
- DOCS Nasdaq
- ASND Nasdaq
- Market Cap
- DOCS 12.3B
- ASND 12.2B
- IPO Year
- DOCS 2021
- ASND 2015
- Fundamental
- Price
- DOCS $49.93
- ASND $206.06
- Analyst Decision
- DOCS Buy
- ASND Strong Buy
- Analyst Count
- DOCS 20
- ASND 17
- Target Price
- DOCS $68.55
- ASND $245.76
- AVG Volume (30 Days)
- DOCS 1.7M
- ASND 460.8K
- Earning Date
- DOCS 11-06-2025
- ASND 11-12-2025
- Dividend Yield
- DOCS N/A
- ASND N/A
- EPS Growth
- DOCS 42.88
- ASND N/A
- EPS
- DOCS 1.25
- ASND N/A
- Revenue
- DOCS $621,329,000.00
- ASND $758,592,045.00
- Revenue This Year
- DOCS $13.54
- ASND $104.98
- Revenue Next Year
- DOCS $11.26
- ASND $79.91
- P/E Ratio
- DOCS $39.96
- ASND N/A
- Revenue Growth
- DOCS 20.21
- ASND 97.46
- 52 Week Low
- DOCS $47.66
- ASND $118.03
- 52 Week High
- DOCS $85.21
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- DOCS 18.25
- ASND 55.05
- Support Level
- DOCS $65.22
- ASND $195.00
- Resistance Level
- DOCS $67.10
- ASND $202.41
- Average True Range (ATR)
- DOCS 2.29
- ASND 8.09
- MACD
- DOCS -1.68
- ASND -0.20
- Stochastic Oscillator
- DOCS 0.55
- ASND 87.46
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.